The NOAH Code of Practice Committee, chaired by Mr Guy Tritton, has found Dechra Veterinary Products in breach of three items of the NOAH Code, following a complaint.
The complaint related to an advertisement and detailer promoting Felimazole with the wording "Are you taking a heavy-handed approach to hyperthyroidism?" and "with Felimazole, you don't have to!"
The Committee took the view that by implication this referred to Vidalta because Vidalta is the only other licensed oral treatment on the market for hyperthyroidism.
As a result, the Committee found both promotions in breach of Clause 4.3 because of the implication that Vidalta is less safe than Felimazole.
The Committee did not consider the promotions disparaged the manufacturer as there is no evidence to show it is unsafe.
The Committee also found that the table in the detailer (page 4) suggesting that one dosage of 5 mg per day of Felimazole has the same efficacy as two doses of 2.5 mg, (which is contrary to the dosing statement within the SPC: "If, for reasons of compliance, once daily dosing with a 5 mg tablet is preferable, then this is acceptable although reduced efficacy can be expected compared to a twice daily regime.") was misleading, contrary to Clause 4.3 of the Code.
Full details of the Committee's rulings are on the NOAH website at www.noah.co.uk/code. The full report of this particular case will be available shortly.
Gabbrovet Multi is the first and only ready-to-use solution licensed to treat both cryptosporidium and E.coli diarrhoea in calves.
The company highlights a study of 334 calves with severe diarrhoea, where those receiving Gabbrovet Multi showed a faster and more effective response than those given halofuginone1.
Harry Walby, ruminant veterinary advisor at Ceva Animal Health, said: “Gabbrovet Multi is the first and only ready-to-use solution for the convenient treatment of both cryptosporidium and E.coli, two of the most common causes of neonatal scour in calves."
Gabbrovet Multi can be administered in milk or water.
It is available with a dosing cap and comes in 250ml, 500ml or 1l presentations.
Gabbrovet Multi also treats gastro-intestinal infections caused by E.coli in pigs.
For further information, contact your local Ceva Animal Health territory manager or email cevauk@ceva.com.
References
The Cheshire-based specialist referral centre provides advanced surgical procedures and specialist veterinary support to practices in north west England and north and mid-Wales.
Its specialist disciplines include orthopaedics, soft tissue surgery, a specialist diabetes clinic, spinal surgery, anaesthesia and intensive care, cardiology, diagnostic imaging, pain management, neurology (medical and surgical), oncology and internal medicine.
Liz Cousins, Northwest's Hospital Manager said: "Following our recent brand transition from Northwest Surgeons to Northwest Veterinary Specialists we are delighted to receive this accreditation.
"The scheme examines every part of what we do, from customer experience, equipment and facilities right through to clinical governance. In a hospital with more than 85 colleagues, that’s a lot of work to do to meet the high standards.
"Our new brand name reflects the range of specialist services we offer and this accreditation gives confidence to fellow veterinary surgeons and pet owners that we really do offer the very best specialist care for pets.
"We continually strive for excellence across the business, and this is another way of demonstrating just how good the specialists are at Northwest Veterinary Specialists."
Picture shows: Matt Gurney, European Veterinary Specialist in Anaesthesia and Analgesia (centre) with Kathryn Humphreys, Head of Nursing, (right), Jenny Pearson, support Services Manager, (left) with the RCVS Hospital Accreditation.
The reports summarise the results of two surveys that were conducted between July and August last year.
Of the 28,718 veterinary surgeons who were sent the survey, 22% fully completed and submitted the questionnaire.
Some of the main findings included:
Around 40% of veterinary surgeons and over 40% of veterinary nurses said they had experienced concerns for their personal safety aside from catching Covid.
These safety concerns mostly related to client interactions at the practice either during the day or out-of-hours.
Many respondents experienced conflict between their personal wellbeing and professional role, and found it difficult to juggle their work and caring responsibilities.
Many respondents also said their mental health was adversely affected by the experience of working during the pandemic.
A large majority of respondents said they had personally seen an increase in caseload due to new animal ownership.
Lizzie Lockett, RCVS CEO, said: “While many of the results of the survey may not be especially surprising and confirm what we have already been told anecdotally, it is very important that we have this hard data to hand on the overall impact of the pandemic on individual members of the professions.
“These two reports complement the six surveys that we have conducted with veterinary practices on the economic impact of the pandemic to give us as clear and holistic a picture as possible about the challenges that the professions and the veterinary sector as a whole have faced since March 2020.
"This not only provides a useful historical snapshot, but builds an evidence base to inform future temporary changes should the pandemic continue into more waves, or should future such crises arise.
“The results of the two individual surveys make it clear it has been a tough time for the professions.
"A good proportion of respondents also acknowledged that positive developments have come from the past two years, including the way the profession has demonstrated remarkable resilience, flexibility and adaptability, as well as forging a stronger team spirit under such difficult circumstances.
“However, a large number of both vets and vet nurses who responded said that the experiences since March 2020 have left them feeling more pessimistic about veterinary work and their place within it.
"I would like to reassure members of the veterinary team that the RCVS is aware and understands.
"We tried throughout the pandemic to support the professions with relevant temporary guidance changes, and we are now working with a range of stakeholders on critical issues such as the workforce crisis, which has been in part caused by Covid.
"We are also developing tools, training and resources to support the professions, via our programmes such as RCVS Leadership and Mind Matters.”
The full coronavirus impact survey reports can be found at www.rcvs.org.uk/publications.
Animalcare has announced the launch of Clavubactin (amoxicillin/clavulanate) for dogs and cats, presented as 4-way split tablets in three strengths to ensure optimum dosing. The three strengths (Clavubactin 50, 250 and 500) contain 50/12.5, 250/62.5 and 500/125mg of amoxicillin and clavulanic acid respectively. Clavubactin 50mg is licensed for cats and dogs. The 250 and 500mg formulation is licensed for dogs only.
According to the company, the increased combined level of active ingredients, compared to some other clavulanate-amoxicillin products on the market, achieves recommended target weight dosing (doses always kept at 12.5mg/kg), even with animals of greater weight, minimising the risk of underdosing.
The 4-way split tablets are designed to facilitate easy and accurate dosing of all sizes of dogs and cats, from 1kg bodyweight (¼ tablet Clavubactin 50) to 50kg (1 tablet Clavubactin 500) and above.
The tablets come in aluminium blister strips of ten tablets in five packaging presentations (Clavubactin 50 and 250 are available in 100 and 250 tablet packs and Clavubactin 500 in 100 tablets).
Animalcare Product Manager Tony Liepman said "Clavubactin allows for optimum target weight dosing and together with the accuracy enabled by SmartTabs easy 4-way split, this gives peace of mind to both vet and client."
The product is supported by dosage charts and dispensing envelopes (the latter is available on request).
For further information contact Animalcare on 01904 487687, speak to your regional Animalcare representative or visit www.animalcare.co.uk/contact-us.
Zoetis says Lokivetmab targets and neutralizes canine interleukin-31 (IL-31), a cytokine associated with atopic dermatitis which sends the itch signal to the brain.
The company has submitted an application for marketing authorisation of the product, which is conditionally licensed in the US and Canada under the name Canine Atopic Dermatitis Immunotherapeutic, in the European Union.
The new data was presented at the 8th World Congress of Veterinary Dermatology (WCVD).
Supporting the efficacy of Lokivetmab in canine AD, Zoetis presented the results of a randomized, double-blind, placebo-controlled dose determination trial to evaluate efficacy of three doses of lokivetmab (0.125, 0.5 or 2.0 mg/kg) in providing relief from the clinical signs of pruritus (itching) and other clinical signs associated with atopic dermatitis in dogs.
Veterinary investigators at 15 clinics enrolled 245 client-owned, live-at-home dogs with chronic atopic dermatitis. Lokivetmab or a placebo was administered by subcutaneous injection on day 0, and efficacy was evaluated periodically over 56 days. Dog owners assessed their dog’s pruritus using a visual analog scale (VAS), and investigators assessed the associated skin lesions using Canine Atopic Dermatitis Extent and Severity Index-03 (CADESI-03) scores.
Lokivetmab, injected once subcutaneously, provided dose-dependent improvement in owner-assessed pruritus and clinician-assessed CADESI-03 scores for four to six weeks in dogs with atopic dermatitis.
Zoetis also presented results of a randomized, double-blind, placebo-controlled trial to assess the safety of lokivetmab at the nominal dose tested of 1 mg/kg (range, 1-3.3 mg/kg) in the treatment of canine atopic dermatitis. Veterinary surgeons evaluated 245 client-owned, live-at-home dogs with chronic, naturally-occurring atopic dermatitis. These dogs were randomized at a 2:1 ratio to receive two monthly injections of lokivetmab (162 dogs) or placebo on days 0 and 28.
No immediate hypersensitivity reactions were observed and there were no clinically important differences in clinical pathology results. No apparent adverse drug interactions were reported. Dogs studied were taking a wide variety of medications, which is important because multimodal therapy is commonly prescribed for dogs with atopic dermatitis. Adverse events were reported at a similar frequency between the groups.
Norbrook has verified that the pH of certain batches has increased over time and is out of specification.
This issue impacts the following batches:
A spokesperson said: "There has been no increased risk to animal safety identified but we take quality extremely seriously so we initiated a voluntary recall. We have informed all of the competent authorities and we are working with our distributor to advise immediate quarantine of any remaining inventory."
If you have any questions concerning the recall, contact Ms. Anita Vanderlaan Tel: +44 (0)28 3026 4435, Email: anita.vanderlaan@norbrook.co.uk
The study1 was led by the RVC’s VetCompass programme and included 22,333 dogs whose health was followed for a year, during which 1,580 were recorded by the vet as overweight; roughly 1 in 14.
The authors point out that this figure is probably just the tip of the iceberg, because not every overweight pet will receive veterinary attention.
The study also found that certain breeds were especially prone to weight gain, including Pugs, Beagles, Golden Retrievers and English Springer Spaniels.
As well as showing that specific breeds were at differing risk, the study also highlighted that being neutered and middle-aged were additionally associated with increasing chances of dogs being overweight.
The main findings were:
Owners are encouraged to discuss their dog’s weight and lifestyle on every visit to their veterinary practice. This is of particular importance in the high-risk dogs identified in this study such as Pugs, Beagles, neutered and middle-aged dogs.
Camilla Pegram, VetCompass Epidemiologist at the RVC, and author of the paper, said: "This study has used the power of “big data” to robustly address the risk factors for obesity in dogs. Pugs, Beagles and Golden Retrievers were at greatest risk of obesity compared with crossbreeds.
"As well as genetics, management style could in part drive these breed predispositions. Whilst veterinary professionals and owners should focus efforts on obesity prevention strategies in all dogs, those identified at high-risk, such as Pugs, Beagles and Golden Retrievers, may need a more targeted approach."
Dr Eleanor Raffan, Associate Lecturer in Systems Physiology, at the University of Cambridge, and co-author of the paper, said:
“Where breed increases risk of a problem, it means genes are likely to be at least in part to blame and our previous work suggests that genetics drives a high appetite in some breeds. The bad news is that owners of food-obsessed dogs have to work much harder to keep their dogs at a healthy weight – the good news is that it can be done.”
Reference
"The majority of veterinary medicines used in the UK (and ingredients and components to make them) are either produced in or enter via the EU. The government is working with animal health companies who have been carrying out extensive contingency planning for all EU Exit scenarios, including no deal. These plans cover all aspects of their supply chains, from regulatory compliance and stocking levels to logistics and customs. They also include, as appropriate, increasing stocks of products in the UK, changing supply routes, transferring marketing authorisations and other regulatory processes.
"To reduce any risk to medicines availability in the UK, detailed planning is ongoing to ensure that supply chain measures are appropriate to address the sector’s complex needs and priorities.
"Much work has been done by companies with the objective of ensuring fair and appropriate distribution of this inventory to avoid disruption.
"Supply is expected to cope with a normal ordering pattern with adequate forward planning and communication with suppliers.
"With this planning in place, we are confident that we have made every effort to ensure continuity of supply of veterinary medicines in the UK."
Well that makes a nice change from the incessantly and determinedly gloomy picture painted elsewhere.
The survey is open to all veterinary surgeon members and participants will be entered into a free prize draw to win £500 of BEVA CPD vouchers.
As we all know, antibiotic resistance is increasing throughout human and veterinary medicine, and there are few new antibiotics being produced. As BEVA says, it’s therefore imperative for vets to protect the usage of antimicrobials to maintain their effectiveness for the future.
To that end, the purpose of the survey is to help fill in gaps in knowledge about how antimicrobials are being used and also the current landscape of resistant infections encountered in equine practice.
The survey has been designed by Amie Wilson and Dr Gina Pinchbeck at the University of Liverpool and Tim Mair the incoming President of BEVA.
Tim said: "This survey will assess any changes in prescribing of antimicrobials in equine practice since the last survey in 2009. In addition, we will collect data on the current frequency and types of antimicrobial resistant infections seen by clinicians in all areas of equine practice and what infection control and audit practices are currently using to combat this."
The survey results should lead to a greater understanding of the role of antimicrobial treatment in the overall epidemiology of antimicrobial resistance in horses and will help protect antibiotics for the future of equine and human health.
To take part in the survey, visit: https://liverpool.onlinesurveys.ac.uk/beva-questionnaire-2019-final
The results will be announced to coincide with European Antibiotic Awareness Day on 18 November 2019.
If you have any questions about the survey you can contact the researchers direct: Amie Wilson, University of Liverpool A.wilson3@liv.ac.uk; Dr Gina Pinchbeck, University of Liverpool ginap@liv.ac.uk; Tim Mair, British Equine Veterinary Association tim.mair@btinternet.com
Barclaycard has launched Paywag, a new NFC payment system for dogs.
Installed in a specially designed dog collar, the new system allows dogs to make payments up to £5.00 in value in selected pet stores and veterinary practices.
Running throughout October, it is Ceva's third TV campaign this year to raise awareness of the benefits of Feliway and Adaptil amongst pet owners.
The campaign starts with a Feliway Classic advertisement running from 3rd October until 16th October, followed by an Adaptil advertisement until 30th October, timed for the run up to the firework season.
The new TV advertising campaign will target 18.5 million pet owners and it will air on all the C4 channels, including Channel 4, E4, More4, Film4, Drama, Good Food, Really, W and Home, with two spots during the popular Channel 4 TV show Great British Bake Off, which has 6.7 million viewers.
The TV advertising campaign will be supported by a Sky Adsmart and social media campaign for ADAPTIL.
Claire Russell, product manager for Feliway and Adaptil at Ceva Animal Health, said: "Our autumn Feliway and Adaptil TV advertising campaign is our biggest, most extensive campaign to date. It demonstrates our commitment to raising awareness of how anxiety in pets can affect the relationship with their owners and how Feliway and Adaptil can help."
For further information, visit www.feliway.com or www.adaptil.com.
The Investigating Committee and the Disciplinary Committee are responsible for conducting desk-top investigations and disciplinary hearings in response to complaints, disclosures and notifications that may amount to serious professional misconduct by Registered Farriers.
As the Royal College of Veterinary Surgeons did in 2015, the FRC is splitting off its disciplinary functions from that of its Council, meaning it now needs to recruit new members to perform the role.
More information is available in VetSurgeon Jobs, here.
Norbrook Laboratories has launched Norfenicol Solution for Injection (florfenicol), a broad spectrum antibiotic licensed for the treatment of pneumonia in cattle and pigs.
Dr Barry McInerney, Norbrook's GB Veterinary Advisor said: "With many farmers preparing for winter housing, the launch of Norfenicol is timely as pneumonia represents the most common disease of housed cattle in the UK costing the agricultural industry an estimated £80m per year. Norfenicol is an easy to inject, cost effective treatment of pneumonia which kills bacteria quickly, and is available in a durable plastic bottle. Studies have shown florfenicol, the active ingredient in Norfenicol, to have a high bacteriological and clinical efficacy (100% and 96% respectively) against susceptible bacteria in the treatment of calf respiratory tract diseases."
Norfenicol is indicated for the treatment of bacterial respiratory disease in cattle associated with Mannheimia haemolytica, Pasteurella multocida, and Histophilus somniand for the treatment of acute outbreaks of respiratory disease caused by strains of Actinobacillus pleuropneumoniae, and Pasteurella multocida in swine.
Dr McInerney added: "NSAIDs have also been shown to be a beneficial ancillary therapy in treating bacterial pneumonia, to alleviate pain as well as to reduce inflammation and pyrexia. Norbrook has a range of NSAID products which are available as an adjunctive treatment for pneumonia in cattle, including Loxicom 20 mg/ml solution for injection for cattle, pigs and horses."
For further product information, visit www.norbrook.com
Armed with the new microscope, New Forest Equine Vets (NFEV) has started offering a mobile equine veterinary service, including expert worming advice.
The microscope captures images with a resolution of 1 micron, with a live magnification of x200 and x400 or more, which means that the practice can carry out an accurate egg count in the yard, rather than sending faecal samples off to the lab.
This, they say, allows for a more a more accurate result, because posting faeces can lead to the sample desiccating and the eggs hatching, leading to false negative results. It also allows the veterinary surgeon to give immediate advice and treatment.
Dr. Beth Robinson BVSc Cert AVP(EP) MRCVS, co-owner of NFEV, says "One of the main aims of performing worm egg counts is to identify horses shedding low numbers of eggs so that we can maintain a low number of parasites on the pasture that have not been exposed to wormers and therefore have not been placed under selection pressure for resistance. In horses shedding high numbers of eggs, worm egg count reduction tests are a useful way of assessing whether treatment has been effective."
Andrew Monk, co-founder of ioLight, said: "The product is incredibly simple to use. By using a tablet both the owner and vet can view the image and discuss treatment. We hope that more horse owners in the New Forest will use the services from NFEV to protect their animals, and that it will encourage other equine practices to purchase a microscope so they can also offer a similar high quality service. We have made a video with NFEV to demonstrate their service and encourage other equine vets to use the ioLight microscope in their own mobile clinics."
Beth added: "We are delighted to be working with ioLight and horse owners to keep their animals healthy and improve equine welfare."
Organisers of The London Vet Show 2009 report that the event was a great sucess, greeted with 'considerable delight' by delegates and exhibitors alike.
The event, which featured clinical and commercial lectures as well as a major exhibition, ran on 6th and 7th November at London's Olympia Conference Centre. 2410 veterinary professionals attended, and most were there for both days.
VetSurgeon.org attended the event, asking commercial exhibitors: "What's New?" Those of you that didn't make it to the show can click here to watch a video of their answers.
Overall feedback from vets about the quality of the CPD programme was overwhelmingly positive. Delegate feedback forms rated the quality of speakers in the programme as 4.39 out of 5, and rated the event as 4.68 out of 5 in terms of value for money.
Rachel Bolus of Riverside Veterinary Practice said: "All the lectures were to a really good standard - a lot of CPD for a very cheap price."
Bridget O'Farrell of Dick Vet Small Animal Practice agreed: "Very cheap for two days of CPD and the quality of the speakers has been very good. I went to five lectures yesterday and planning on six today. It's been a very worthwhile exercise and I would certainly recommend this to my peers".
Event organiser Phil Nelson said: "We have witnessed an amazing two days, surpassing all delegate estimates and it's gone down really well. The 2010 exhibition is already 40% bigger than this year almost 12 months out and looks set to sell out. We are carefully listening to the delegates and exhibitors comments, and have already a number of plans to develop and build the event going forward. But as a starting point we could never have dreamt for the launch event to be so well received."
For 2010 the London Vet Show is moving to the bigger Olympia National Hall having out grown the Conference Centre. It will run on October 22nd and 23rd. It is committed to retaining the same approach to offering affordable and World Class CPD qualifying clinical and commercial content for all the UKs vets. Having very quickly established itself as a major part of the veterinary calendar the organisers expect to announce their 2010 programme in the early part of 2010.
The British Veterinary Association has welcomed the tightening up of sales of veterinary medicines on the internet but has expressed disappointment that the advertising of antimicrobials to farmers will continue.
The Veterinary Medicines Directorate has today published its response to the public consultation on the Veterinary Medicines Regulations, which are updated every year.
The new Regulations, which come into force in April 2011, introduce new controls on internet pharmacies meaning that only approved websites will be legally allowed to dispense and supply veterinary medicines. The controls will come into force in April 2012 and the BVA supports the use of a logo on approved websites to help consumers buy medicines from reputable sources.
The BVA has previously expressed concern that pet owners could inadvertently buy counterfeit veterinary medicines online and urges veterinary clients to seek advice from their vet and only buy from UK-based companies.
Harvey Locke, President of the BVA, said: "Without proper regulation online pharmacies could be sourcing drugs from overseas and selling counterfeit medicines that look genuine to unsuspecting pet owners. These medicines are placebos at best and dangerous at worst.
"We therefore welcome the VMD's decision to clampdown on irresponsible online retailers and provide a clear logo for approved websites that will give pet owners confidence.
"We have also asked the VMD to put a stop to the increasing problem of prescription fraud and we hope the tighter regulation announced today will be a step towards achieving that aim.
"However, we would urge all pet owners to continue talking to their vet about sourcing medicines from the internet to make sure the right drugs are bought and administered correctly."
In light of increasing concerns about the growth of antimicrobial resistance the VMD's consultation canvassed views on restricting the advertising of antimicrobials to farmers. The BVA says it supported a ban on advertising as a sensible approach to the responsible use of antimicrobials, and is disappointed that the VMD has decided not to go ahead with it. Mr Locke said: "New antimicrobials are heavily advertised by pharmaceutical companies to vets and farmers so it is vital that the message of responsible use is not lost.
"Antimicrobial resistance is a serious issue for both animal and human health and we are disappointed that the VMD is not restricting the advertising of these products to farmers. The pharmaceutical companies must now undertake to advertise responsibly.
"Ultimately, it is the veterinary surgeon who will make the decision on which veterinary products to use and vets and farmers should work together to ensure antimicrobials are used prudently and responsibly."
Matt has taken over as hospital director from David Walker, who has now moved to the role of referrals managing director in the south of the UK for Linnaeus.
Matt said: “I certainly have some big shoes to fill but working as clinical director alongside David was a great grounding and we work well together.
“Essentially, I was his running mate back then but now I am stepping up to take on the main role, with all the additional responsibilities it entails, and I’m determined to make it my own.
“I know I have the drive, the desire, the clarity of purpose and the dedication to succeed.
"I also know what an incredible operation I have inherited from David.
“One of the key things about Anderson Moores is that every member of the team works together in the same location to support every aspect of a pet’s treatment and recovery, so whatever service they may need is all available under the same roof.”
www.andersonmoores.com/homewww.zeropainphilosophy.com
The first, which covers three topics: canine uveitis, canine glaucoma and non-healing corneal ulcer, is for the entire practice. It normally costs £95 per practice, but for VetSurgeon.org members, it's £70.
To book, visit: https://docs.google.com/forms/d/e/1FAIpQLScSSbUDCcC53cvPJtj1oPkJFEoDjJ3Tdij_y9iFtr7emBvkoQ/viewform?usp=pp_url
The second course is 'Ophthalmic Examination in the Dogs and Cats', which costs £25 for VetSurgeon.org members, that is reduced to £15 per person.
To book, visit: https://docs.google.com/forms/d/e/1FAIpQLSfnBizM5NmFGwWeDqtdXy9zCq8KdFgGI2e5D8pjuWOTuPln0Q/viewform?usp=pp_url
Originally from Belgium, Tamir, who qualified at Glasgow in 2001, started Vision Vet in 2009 and gained his National French Certificate in Ophthalmology (broadly equivalent to the UK Cert) in 2011.
https://www.vision-vet.co.uk
The award, funded by the Economic and Social Research Council (ESRC) working in partnership with the Department of Health and the Arts and Humanities Research Council (AHRC), is part of the cross-council 'Tackling antimicrobial resistance: behaviour within and beyond the healthcare setting’ call, part of the antimicrobial resistance cross-council initiative supported by the seven research councils in partnership with other UK funders including the Medical Research Council (MRC).
The research team will be led by social scientists at the University of Exeter and includes two veterinary surgeons from the University of Bristol’s School of Veterinary Sciences, together with colleagues at the Innogen Institute of the University of Edinburgh, the British Veterinary Association and leading farm animal veterinary surgeons across the UK.
The researchers say that better, smarter, more rapid and more accessible diagnoses - driving shifts in behaviour associated with diagnostic decision making - represent a critical step to delivering more effective uses of antibiotics in animal health. But improvements in diagnostic development and their relationship to prescription and treatment requires social, governance and technical innovations.
Professor Henry Buller, project lead from the University of Exeter’s School of Geography, said: "This is an exciting opportunity to provide a current assessment of diagnostic and treatment decision practices in the livestock sectors of the UK. Novel and innovative diagnostic tools are currently in development, and our research will generate better understanding of their development as well as the marketing and regulation of these new technologies."
Dr Kristen Reyher, Senior Lecturer in Farm Animal Science, who is the lead on the project at the University of Bristol’s School of Veterinary Sciences, added: "Our research team – the AMR Force – has a track record of working closely with farmers, veterinarians, retailers and government bodies to encourage responsible use of antibiotics. We are excited to have this amazing opportunity to collaboratively generate, evaluate and analyse behaviours and strategies around animal disease diagnosis and to show how innovation in the development of diagnostic tools along with diagnostic regulation and governance can lead to more sensible use of antibiotics across farming systems.
"Working with our partners, we will identify pathways and possibilities for improved diagnostic practice and will trial new diagnostic tools on a series of farms. We are very excited to take our ideas beyond the UK as well, and will conduct pilot and capacity-building research in Tanzania and also partner with a project working in Bangladesh that is co-funded by ESRC and the Centre for Environment Fisheries and Aquaculture Science."
Professor Buller added: "Employment of new diagnostics doesn’t occur in a vacuum. Our team will evaluate the implications these innovations will have for the organisation, cost-effectiveness and efficiency of veterinary practice, as well as for veterinary training. We will identify the changes in behaviour, practice and knowledge necessary to accompany the more widespread adoption of practices that are deemed effective and will assess the regulatory and governance support necessary to encourage use of beneficial practices."
The interdisciplinary team will work alongside diagnostic tool developers and regulators, veterinary practices and professional bodies, farmers and treatment decision makers, veterinary laboratories, the food industry and government regulatory authorities to develop durable and innovative strategies for facilitating and advancing smarter approaches to the use of antibiotics in agriculture.
The work will cover the major livestock species, and will involve seeking opinions from veterinary surgeons across the country, through collaboration with the BVA.
David Barrett, Professor of Bovine Medicine, Production and Reproduction at the University of Bristol’s School of Veterinary Sciences, said: "This is a fantastic opportunity to assess the adaptability and responsiveness of the different animal production sectors - poultry, pigs and cattle - along with a variety of veterinary structures to the trialled innovations in diagnosis and diagnostics, and will determine the likely benefits of these innovations for prescription practice, for animal health and for sustainable livestock production."
Photo: University of Bristol
CVS says that in the USA, the veterinary profession is the fifth highest profession for non-fatal injuries, with equine veterinarians sustaining an average of eight serious injuries during their career.
‘The context, consequence and prevention of veterinary workplace injuries: a qualitative and quantitative study in the UK’ will be undertaken at the University of Liverpool in collaboration with CVS colleagues as part of its Clinical Research Awards.
The study will run for three years, supported by £74,400 of CVS funding.
The research will investigate what veterinary injuries are, what context they occur in and what their consequences are.
It will look to highlight areas of the profession where injury prevention training and strategies can be developed and adopted to improve the safety of working in veterinary practice.
For the first phase, University of Liverpool researchers have rolled out the largest ever survey to explore veterinary workplace injuries with over 5,000 CVS staff UK-wide.
The survey investigates how veterinary professionals define injuries, their specific causal mechanisms, and why individuals do or do not report injuries or seek medical treatment.
The survey will be followed by an independent audit of CVS’ accident reporting system.
The results of these two activities will lead to the development of a suite of industry leading ‘open access’ educational tools aimed at promoting injury awareness and prevention to help drive behaviour change and support injury avoidance.\
The research project is being led by Dr. John Tulloch, a Research Fellow and European Specialist in Veterinary Public Health, at the University of Liverpool.
Collaborators include CVS Head of Health and Safety Rebecca Jackson and Director of Learning, Education and Development Dr Martin Whiting.
John said: “Injuries that occur within veterinary practice can tragically at times be life-changing and are often avoidable.
"Currently we do not know some critical details that would help to improve safety within the veterinary workplace.
"If we can better understand these details, we will be able to develop and strengthen prevention measures through policy, education, and training.
"We anticipate that this project will result in safer workplaces within the wider veterinary community and, indirectly, in improved animal treatment through a fitter, healthier and safer profession.”
The PAW Report, which monitors pet welfare issues across the UK, is produced in conjunction with YouGov. Over 63,000 pet owners have been surveyed since 2011, providing the most robust insight into the welfare of UK pets.
For the first time, each section of the report ends with a veterinary action area that highlights the main issues, suggests what veterinary surgeons and nurses can do to tackle them, and lists resources that are available to help.
This year's PAW Report shows that just 75% of dogs (7.0 million) and 65% of cats (6.7 million) received a primary vaccination course when young. These are the lowest levels ever recorded by the Report and compares with 82% of dogs and 72% of cats in 2011.
Only 66% of owners (5.6 million cats, 7.3 million dogs, 500,000 rabbits) surveyed in 2017 have protected their pet with annual booster vaccinations.
Rabbits remain the most neglected with only 50% receiving a primary vaccination when young, a decrease from 63% in 2016, and 55% not receiving their annual booster vaccinations.
PDSA Head of Pet Health and Welfare, Nicola Martin, said: "The decreasing number of dogs, cats and rabbits receiving primary and booster vaccinations is a great concern for the health and welfare of the nation's pets."
20% of both dog and cat owners and 10% of rabbit owners who hadn't vaccinated their pets gave 'too expensive' as their reason for not vaccinating.
Nicola added: "While the latest PAW Report confirms that many of us get pets for the companionship and love they bring to our lives, it also highlights many owners continue to misjudge the costs involved in owning a pet. Despite potential lifetime costs of dog ownership easily rising to £21,000, the Report revealed 98% of dog owners surveyed estimated that their dog would cost less than this over the dog’s lifetime. This shows that the veterinary profession and animal welfare organisations need to do more to raise awareness of the financial reality of pet ownership – including preventive care and veterinary treatment – before owners take on a pet."
Of those owners who hadn't vaccinated their pets, 14% of dog owners, 22% of cat owners and 32% of rabbit owners felt vaccinations were unnecessary. 24% of pet owners who hadn’t vaccinated their pets said that this is because their pet didn’t come into contact with other pets.
Nicola continued: "These findings show there’s a real lack of knowledge of the devastating diseases pets are susceptible to if they’re not protected through vaccination. It’s important we improve vaccination levels before we face a resurgence of pets suffering with vaccine-preventable diseases."
John Chitty, President of the BSAVA said: "The current vaccination levels in cats and rabbits are far below the levels expected to provide a 'herd immunity effect' with the consequence that significant reductions in these diseases are further away, and those pets not vaccinated are at even greater risk.
"In particular it is deeply worrying to see the fall in vaccinated rabbits. The recent advances in myxomatosis vaccines mean that it is now much easier and cheaper to ensure more complete protection of pet rabbits from what is a common and lethal disease. The advent of RHD-2 virus in the last couple of years also seems to have failed to stimulate more owners seeking vaccination for their rabbits, especially given the publicity that this has generated."
In response to the report findings, the PDSA is launching ‘Spread the word, not the disease’, a campaign to help raise awareness, spread the word about preventable deadly diseases, and encourage pet owners to get their pets vaccinated and ensure their boosters are up-to-date.
The PDSA is asking people to pledge their support at: www.pdsa.org.uk/spreadtheword
Nicola concluded: "It’s up to the veterinary profession to help educate pet owners on the importance and value of vaccination. This is an area which requires collaboration and a co-ordinated effort across veterinary bodies to ensure owners can make informed decisions about vaccination. By launching this campaign, we hope to raise awareness of the risks these diseases pose, and how important vaccinations are in protecting the long-term health and wellbeing of the nation’s pets."
The full report can be downloaded here: https://www.pdsa.org.uk/get-involved/our-current-campaigns/pdsa-animal-wellbeing-report
About the PAW Report
All figures, unless otherwise stated, are from YouGov Plc. Total sample size was 4,153 dog, cat and rabbit owners aged 18+ who live in the UK. Fieldwork was undertaken between 23 February and 6 March 2017. The survey was carried out online. The figures have been weighted and are representative of the population by pet species (cat, dog or rabbit owners) and the owner’s gender, age and region.
Extrapolations to pet population figures are based on the following estimates of pet populations in the UK: 9.3 million dogs, 10.3 million cats, and 1.1 million rabbits.
Over 90% of the 156 respondents (predominantly vets, but also managers) believed CT was important in first opinion practice, but nearly half did not have access to a scanner.
25% said they were interested in buying a CT scanner, mainly for the improved diagnostics and desire to keep more cases in-house.
The main reasons for not buying a CT scanner were: space, cost and lack of confidence.
Matt Winter, radiologist and CVMO at VetCT said: “Imaging in first opinion practice is evolving rapidly with innovations in veterinary-specific CT technology, modern machines are more available and affordable than ever.
"We need to build confidence through training and understanding of the technology, and the comprehensive support available to practices.”
While practices with a CT scanner felt they were using it optimally for the most part, specialist radiologist reporting emerged as the most significant factor towards optimising its use.
However, a third of respondents not currently using teleradiology (the remote reporting by specialist radiologists of diagnostic images acquired by a practice), said they did not know enough about it and/or hadn’t considered it.
Matt said: “Expert teleradiology to support with image interpretation is enabling more practices than ever to offer advanced imaging and provide state-of-the-art diagnostics for patients, meeting growing client expectations, elevating patient care and improving outcomes."
VetCT’s webinars on CT optimisation are available on Youtube: https://www.youtube.com/c/Vetctspecialists
The RCVS is seeking feedback on a new draft Code of Professional Conduct.
The new Code, which would replace the existing RCVS Guide to Professional Conduct for Veterinary Surgeons, has been produced by a Working Party set up by the RCVS Advisory Committee to review the Guides for both veterinary surgeons and veterinary nurses.
According to the College, the purpose of the review, which last took place over a decade ago, is to ensure guidance to the profession and the public is clear. For example, using consistent language to distinguish between what must be done and what is advised.
The RCVS says the new Code is a short, principles-based document using the Federation of Veterinarians of Europe's Code of Conduct as the starting point. It will be supported by additional advice on specific areas of veterinary practice or issues, for example, clinical governance. It also includes:
Clare Tapsfield-Wright, Chairman of the Guides Review Working Party said: "Over the decade or so since it was last reviewed, not only has the Guide become unwieldy in places, but the way that regulators in general publish professional conduct rules has changed. Our draft new Code aims to clarify matters and bring us into line with best practice elsewhere.
"Animal owners are increasingly keen to understand the basis of what the veterinary profession considers to be good professional conduct. The new simplified Code should assist with this understanding."
The new Code, together with the consultation paper, can be downloaded at http://www.rcvs.org.uk/codeconsultation
Comments, which are welcomed from the profession and the public, should be sent by email to Christopher Murdoch, Secretary to the Guides Review Working Party, at c.murdoch@rcvs.org.uk by Friday, 24 June 2011.
A separate document is under development for veterinary nurses, which will share broadly similar underlying principles and will be the subject of its own consultation.
Given the improbability of anyone being alerted by a goldfish: "blub-blub-behind-blub-you-blub-blub-the-blub-frying-blub-blub-pan-is-blub-on-fire-blub", one has to presume the respondents were talking about dogs.
But no, according to npower, 10% of the participants in its survey reported that their cat or dog had directly saved their life, or the life of someone they know.
Really? Saved by a cat? I should have thought a cat would be more likely to turn on it's heels and strut out of the room nonchalantly.
Still, the point of the npower's research was to highlight the dangers of carbon monoxide. In its press release, the company pointed out that pets can suffer CO poisoning symptoms of vomiting, tiredness and erratic behaviour before people.
So perhaps that's what the cat owners meant when they'd been saved by the cat: like a miner would say they were saved by a canary.